Drug Profile
Gavestinel
Alternative Names: GV 150526; GV 150526ALatest Information Update: 10 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Indoles; Neuroprotectants; Small molecules
- Mechanism of Action Glycine gated NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke